Skip to content

the Efficency and Safety of Stretta in GERD

the Efficency and Safety of the Endoscopic Radiofrequency Procedure in Gastroesophageal Reflux Diseases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03574831
Enrollment
60
Registered
2018-07-02
Start date
2016-01-02
Completion date
2021-12-01
Last updated
2018-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD, Radiofrequency Ablation

Keywords

GERD, Radiofrequency ablation, efficiency, safety

Brief summary

This study evaluated the efficency and safety of the endoscopic radiofrequency procedure(Stretta) in adult gastroesophageal patients.

Detailed description

Gastro-esophageal reflux disease (GERD) is the most common outpatient diagnosis in gastroenterology and is associated with a significant burden on the healthcare system. Proton pump inhibitors (PPIs) are the mainstay of GERD treatment,howerver, some patients have an unsatisfactory response to high doses of PPIs, which remains a challenge. The Stretta procedure, a radiofrequency (RF) application to the lower esophageal sphincter (LES), was introduced about 15 years ago as an alternative to chronic medical therapy or surgical intervention for GERD.The Stretta procedure appears to result in thickening of the LES, decreased transient LES relaxation rate and reduced esophageal acid exposure.The majority studies of Stretta were held in USA and Europe, the sduty of Stretta in Asia is rare. The investigators propose to perform a prospectively observiton study to evaluate the efficency of the Stretta procedure in patients of refractory GERD in China.

Interventions

DEVICEStretta

Stretta

Sponsors

Capital Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age \> 18 years 2. Small hiatus hernia (\< 2-3 cm) 3. Los Angeles Grade 'A' or 'B' Reflux Esophagitis or non erosive esophagitis 4. LES pressure \<15 mm Hg 5. PPI dependent / refractory GERD 6. abnormal 24h esophagus pH-impedance monitoring

Exclusion criteria

1. Age \< 18 years 2. Large hiatus hernia (\> 3 cm) 3. Los Angeles Grade 'C' or 'D' Reflux Esophagitis 4. LES pressure \> 15 mm Hg 5. Underlying coagulation disorder 6. Previous Esophageal or Gastric surgery 7. Pregnant 8. major esophagus motility disorder according to Chicago v3.0

Design outcomes

Primary

MeasureTime frameDescription
GERD-HRQL scores[Time Frame: Change from Baseline HRQL scores at 1 month;Change from Baseline HRQL scores at 2 months;Change from Baseline HRQL scores at 6 months;Change from Baseline HRQL scores at 1 year]the improvement of GERD-HRQL scores after procedure.Scale ranges 0-50 points, the lower score means the better efficacy.

Secondary

MeasureTime frameDescription
Number of patients who report independence from Proton Pump Inhibitor (PPI) drug post Stretta procedureChange from Baseline number at 1 month;Change from Baseline number at 2 months;Change from Baseline number at 6 months;Change from Baseline number at 1 year]Questionnaire will be provided to each participant to report no further requirement of PPI drug post procedure.
Demeester Score1 yearthe change of Demeester scores after procedure. The lower, the better.
LES Pressure1 yearthe change of LES pressure after procedure.The higher, the better.
Number of participants with treatment-related adverse events1 monthNumber of participants with treatment-related adverse events

Countries

China

Contacts

Primary ContactHao Zi Guo, MD
zihaoguo@139.com86+15801227696

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026